Patient Power®
Get Email Alerts!
Health Topics
View all Health Topics >

ASH 2011

Featured Video

Video interview from ASH 2011 with Dr. Michael Deininger

Watch Now

Dr. Michael Mauro explains the questions patients and their physicians should be asking themselves.

Watch Now

Dr. Carlo Gambacorti-Passerini, one of the drug's investigators, gives us an update from ASH 2011

Watch Now

with Greg Stephens, Executive Director of the National CML Society (NCMLS)

Watch Now

Dr. Neil Shah explains molecular response and treatment interruption updates from ASH 2011

Watch Now

Dr. Michael Mauro explains how rapid diagnostics, a team approach and personalized care have made OHSU a leader in CML care.

Watch Now

Dr. Druker shares how CML research has forwarded the personalized medicine approach for the treatment of many more cancers.

Watch Now

Dr. Jorge Cortes covers the latest thinking on CML from ASH 2011.

Watch Now

Dr. Jorge Cortes explains the importance of a robust initial treatment response and describes the options available for patients and their doctors.

Watch Now

Dr. Druker shares his passion and optimism for the continued advancement of CML research and treatment.

Watch Now

Foreign Language Videos

Watch Now

Video update mit Dr. Michael Deininger von der Universität Utah, Huntsman Cancer Institute

Watch Now

Prominent LMC ricercatore, il dottor Carlo Gambacorti-Passerini, ci dà un aggiornamento sul bosutinib, un inibitore della tirosina chinasi più recente (TKI) ...

Watch Now

Get Email Updates:

Get updated automatically when new content about Chronic Myelogenous Leukemia has been posted.
Privacy Policy
Chronic Myelogenous Leukemia